Lataa...
Exploiting Apoptosis for Therapeutic Tolerance Induction()
Immune tolerance remains the most promising, yet elusive, strategy for treating immune-mediated diseases. An experimental strategy showing promise in phase 1 clinical studies is the delivery of antigen cross-linked to apoptotic leukocytes using ethylene carbodiimide. This approach originated from de...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3845408/ https://ncbi.nlm.nih.gov/pubmed/24244028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1302070 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|